Episode 50: The MajesTEC-3 Trial in Myeloma

Dr. Vincent Rajkumar of the Mayo Clinic joins the Healthcare Unfiltered EXPRESS to highlight a major study recently published in the NEJM concerning patients with R/R multiple myeloma. This study is arguably changing the standard of care for relapsed disease. We discussed the study, its rationale, its implications, and limitations.Here is a link to the actual publication: https://www.nejm.org/doi/full/10.1056/NEJMoa2514663Please subscribe, rate, share, review, and join the conversation.